Image 01
Chemical structure of loteprednol etabonate, displaying its molecular formula C24H31ClO7 and molecular weight 466.96.*
Zylet Suspension/ Drops
Product Images NDC 24208-358
3 FDA label images from Bausch & Lomb Incorporated · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zylet (NDC 24208-358). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 02
Chemical structure of the active ingredient loteprednol etabonate and tobramycin shown by its molecular formula C18H37N5O9 and a structural diagram with molecular weight 467.52.*
Image 03
Packaging label for Zylet ophthalmic suspension containing loteprednol etabonate 0.5% and tobramycin 0.3%, sterile, in a 10 mL bottle. The label from Bausch & Lomb Incorporated features usage instructions, storage conditions, and active/inactive ingredient details. The label prominently states 'For topical ophthalmic use only' and 'Rx only.'*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
